Loading
Latest filing published 06 Mar 2023 for Concert Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Christi van Heek is a declared insider of Concert Pharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 10 June 2021 to 6 March 2023, the count stands at 4 filings.
The open-market record is one-sided, with 1 purchase worth €47k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants.
The latest filing, published on 6 March 2023, reports a transaction in Concert Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,595 days ago, on 6 June 2022. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations